1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CELLECTIS - ADR
Cellectis - ADR XNAS: CLLS

Cellectis - ADR Live Share Price Today, Share Analysis and Chart

Await Turnaround
about

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the fi...

Read More
1.58 -0.07 (-4.24%)
34.98% Fall from 52W High
37,406
XNAS Volume

XNAS 03 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
33.3 / 100
Valuation Score
Mid Valuation
33.2 / 100
Momentum Score
Technically Neutral
52.0 / 100
Await Turnaround These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks. View Similar Embed DVM
Analyst Price Target
6
1Yr Price target upside is 264%
4 analysts

13

S

10

W

2

O

1

T

SWOT Analysis

Cellectis - ADR Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..